News on NeuroMetrix, Inc.

NeuroMetrix Reports Agreement with GSK Healthcare on 2019 Quell Joint Development Program and Modification to Strategic Collaboration

December 11, 2018 • GlobeNewswire

... WALTHAM, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported momentum in its strategic collaboration with GSK Consumer ...

NeuroMetrix to Present at the LD Micro 11th Annual Main Event on December 5, 2018

November 28, 2018 • GlobeNewswire

... WALTHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO ...

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

November 20, 2018 • GlobeNewswire

... WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued ...

NeuroMetrix Announces DPNCheck Collaboration Agreement with Fukuda Denshi for Japan Market

November 15, 2018 • GlobeNewswire

... WALTHAM, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), announced today that it had executed a distribution agreement with Fukuda ...

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

November 1, 2018 • ICT Monitor Worldwide

... (GlobeNewswire) - NeuroMetrix, Inc.(Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued ...

NeuroMetrix Reports DPNCheck to be Featured at Upcoming 33rd Japan Society of Diabetic Complications Annual Meeting in Tokyo

October 18, 2018 • GlobeNewswire

... WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that DPNCheck®, its rapid, point-of-care test for diabetic peripheral neuropathy ...

NeuroMetrix Reports Q3 2018 Financial Results

October 17, 2018 • GlobeNewswire

... WALTHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended ...

NeuroMetrix, Inc. filed form 10-Q

October 17, 2018 • SEC

NeuroMetrix, Inc. Announces Date for 2018 Third Quarter Financial Results Conference Call

October 10, 2018 • GlobeNewswire

... WALTHAM, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 third quarter ...

NeuroMetrix Reports Publication of New Clinical Study on Quell Wearable Pain Relief Technology

October 2, 2018 • GlobeNewswire

... WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported publication of a clinical study of Quell® wearable pain ...

Subscribe now for full coverage on NeuroMetrix, Inc.

Start My Free Trial